| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 21
| Issue : 2 | Page : 114-118 |
|
|
C-reactive protein in elderly and pregnant COVID-19 cases: A new role for an old marker
Eham Amer Ali1, Dina Akeel Salman2, Wassan Nori2
1 Department of Chemistry and Biochemistry, College of Medicine, Mustansiriyah University, Baghdad, Iraq
2 Department of Obstetrics and Gynecology, College of Medicine, Mustansiriyah University, Baghdad, Iraq
Correspondence Address:
Dr. Wassan Nori
Department of Obstetrics and Gynecology, College of Medicine, Mustansiriyah University, Baghdad
Iraq
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/mj.mj_54_22
|
|
|
The clinical characteristics and prognosis of high-risk groups, including elderly and pregnant women, may vary according to the overall susceptibility of novel coronavirus. For that, numerous researchers worldwide have concentrated their efforts on finding a trustworthy biomarker that can determine the severity, prognosis, and survival of those affected. C-reactive protein (CRP), an inflammatory biomarker that showed higher levels in coronavirus 2019 (COVID-19) cases, underlay inflammation degree and was used to gauge the severity of COVID-19. In this review, we discuss whether CRP might have other uses in COVID-19 cases besides predicting the severity and the clinical outcomes among vulnerable risk groups. Doctors must analyze CRP levels along with the period of illness to identify those liable for rapid progress and be able to categorize case severity to guide the clinical decision to improve prognosis. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
